Burning Rock Biotech Limited American Depositary Shares
Symbol: BNR (NASDAQ)
Company Description:
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
- Today's Open: $10
- Today's High: $10.69
- Today's Low: $9.95
- Today's Volume: 51.35K
- Yesterday Close: $10.36
- Yesterday High: $10.42
- Yesterday Low: $10
- Yesterday Volume: 36.03K
- Last Min Volume: 1
- Last Min High: $10.69
- Last Min Low: $10.69
- Last Min VWAP: $10.69
- Name: Burning Rock Biotech Limited American Depositary Shares
- Website: https://www.brbiotech.com
- Listed Date: 2020-06-12
- Location: ,
- Market Status: Active
- CIK Number: 0001792267
- SIC Code:
- SIC description:
- Market Cap: $109.28M
- Round Lot: 100
- Outstanding Shares: 10.77M
- Asset Type: ADRC
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-08 | 6-K | View |
| 2025-06-06 | 6-K | View |
| 2025-04-29 | 20-F | View |
| 2025-03-25 | 6-K | View |
| 2024-12-31 | 6-K | View |
| 2024-12-04 | 6-K | View |
| 2024-12-03 | 6-K | View |
| 2024-11-27 | UPLOAD | View |
| 2024-11-26 | CORRESP | View |
| 2024-11-26 | 20-F/A | View |
| 2024-11-14 | SC 13G/A | View |
| 2024-10-31 | UPLOAD | View |
| 2024-09-27 | 6-K | View |
| 2024-09-20 | 6-K | View |
| 2024-09-18 | 424B3 | View |
| 2024-09-06 | 6-K | View |
| 2024-08-23 | 6-K | View |
| 2024-08-19 | 6-K | View |
| 2024-06-03 | 6-K | View |
| 2024-05-29 | 6-K | View |
